These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34804776)

  • 1. Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study.
    Van Vugt TAG; Heidotting J; Arts JJ; Ploegmakers JJW; Jutte PC; Geurts JAP
    J Bone Jt Infect; 2021; 6(9):413-421. PubMed ID: 34804776
    [No Abstract]   [Full Text] [Related]  

  • 2. S53P4 BIOACTIVE GLASS PUTTY IN THE LOCAL TREATMENT OF CAVITARY CHRONIC OSTEOMYELITIS.
    Reis GNBD; Cuba GT; Targa WHC; Miras PSC; Bongiovanni JC; Salles MJ; Reis FBD; Dell'aquila AM
    Acta Ortop Bras; 2023; 31(1):e258453. PubMed ID: 36844131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive glass S53P4 to fill-up large cavitary bone defect after acute and chronic osteomyelitis treated with antibiotic-loaded cement beads: A prospective case series with a minimum 2-year follow-up.
    Kojima KE; de Andrade E Silva FB; Leonhardt MC; de Carvalho VC; de Oliveira PRD; Lima ALLM; Roberto Dos Reis P; Silva JDS
    Injury; 2021 Jul; 52 Suppl 3():S23-S28. PubMed ID: 34116851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections - A Multinational Study.
    Lindfors N; Geurts J; Drago L; Arts JJ; Juutilainen V; Hyvönen P; Suda AJ; Domenico A; Artiaco S; Alizadeh C; Brychcy A; Bialecki J; Romanò CL
    Adv Exp Med Biol; 2017; 971():81-92. PubMed ID: 28050878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilisation of bioactive glass S53P4 inside an induced membrane for severe bone defect with high risk of infection: a multi-center preliminary experience.
    Aurégan JC; Villain B; Glombitza M; Blokhuis T; Heinänen M; Bégué T
    Injury; 2022 Oct; 53 Suppl 2():S13-S19. PubMed ID: 35871084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and complications of S53P4 bioactive glass in chronic osteomyelitis and septic non-unions: a retrospective single-center study.
    Gatti SD; Gaddi D; Turati M; Leone G; Arts JJ; Pessina F; Carminati M; Zatti G; De Rosa L; Bigoni M
    Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):489-499. PubMed ID: 38195783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study.
    Romanò CL; Logoluso N; Meani E; Romanò D; De Vecchi E; Vassena C; Drago L
    Bone Joint J; 2014 Jun; 96-B(6):845-50. PubMed ID: 24891588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.
    Malat TA; Glombitza M; Dahmen J; Hax PM; Steinhausen E
    Z Orthop Unfall; 2018 Apr; 156(2):152-159. PubMed ID: 29665602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis.
    McAndrew J; Efrimescu C; Sheehan E; Niall D
    Ir J Med Sci; 2013 Sep; 182(3):509-11. PubMed ID: 23292733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive glass for long bone infection: a systematic review.
    Aurégan JC; Bégué T
    Injury; 2015 Dec; 46 Suppl 8():S3-7. PubMed ID: 26747915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis.
    Lindfors NC; Hyvönen P; Nyyssönen M; Kirjavainen M; Kankare J; Gullichsen E; Salo J
    Bone; 2010 Aug; 47(2):212-8. PubMed ID: 20624692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of Bioactive glass S53P4 in bone infections: a systematic review.
    Bigoni M; Turati M; Zanchi N; Lombardo AS; Graci J; Omeljaniuk RJ; Zatti G; Gaddi D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(2 Suppl):240-251. PubMed ID: 30977891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Cavitary Bone Defects in Chronic Osteomyelitis: Biogactive glass S53P4 vs. Calcium Sulphate Antibiotic Beads.
    Ferrando A; Part J; Baeza J
    J Bone Jt Infect; 2017; 2(4):194-201. PubMed ID: 29119078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of infected tibial non-unions using a BMAC and S53P4 BAG combination for reconstruction of segmental bone defects: A clinical case series.
    Van Vugt TAG; Geurts JAP; Blokhuis TJ
    Injury; 2021 Jun; 52 Suppl 2():S67-S71. PubMed ID: 33039177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Study of One-Stage Treatment of Chronic Osteomyelitis with Bioactive Glass S53P4.
    Geurts J; van Vugt T; Thijssen E; Arts JJ
    Materials (Basel); 2019 Sep; 12(19):. PubMed ID: 31574970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study.
    Drago L; Romanò D; De Vecchi E; Vassena C; Logoluso N; Mattina R; Romanò CL
    BMC Infect Dis; 2013 Dec; 13():584. PubMed ID: 24325278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Bioactive Glass S53P4 as a Treatment for Diabetic Foot Osteomyelitis.
    De Giglio R; Di Vieste G; Mondello T; Balduzzi G; Masserini B; Formenti I; Lodigiani S; Pallavicini D; Pintaudi B; Mazzone A
    J Foot Ankle Surg; 2021; 60(2):292-296. PubMed ID: 33358382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and Predictors of Treatment Failure in Chronic Osteomyelitis Using Bioactive Glass Granules and Putty Formulations.
    Dell'Aquila AM; Reis GNBD; Cuba GT; Targa WHC; Bongiovanni JC; Durigon TS; Salles MJ; Reis FBD
    Antibiotics (Basel); 2023 Dec; 12(12):. PubMed ID: 38136754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive glass, a new tool for the treatment in the diabetic foot recalcitrant osteomyelitis: A case series with 24-month follow-up.
    Rodríguez Á; Parra G; Cuervas-Mons M
    Foot (Edinb); 2021 Sep; 48():101831. PubMed ID: 34390944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.
    Cunha MT; Murça MA; Nigro S; Klautau GB; Salles MJC
    BMC Infect Dis; 2018 Apr; 18(1):157. PubMed ID: 29614973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.